Six peptides received narrow advisory support for potential 503A Bulks List inclusion, an atypical outcome given FDA staff recommendations against all seven under review. Legal compounding remains ...
EBV seroconversion confers markedly increased MS risk in large longitudinal military cohorts, supporting EBV as necessary but ...
High-frequency, low-dose rituximab achieved ~85% peripheral CLL clearance within 1 hour and ~34% nodal reduction in 1 week, with macrophage phagocytosis and complement as dominant mechanisms.
Right-sided performance improved most, with adenoma detection rising from 18.0% to 31.8%, addressing a common vulnerability of standard colonoscopy quality and missed proximal lesions.
The study, “Geographical Access to Preferred Pharmacies in Medicare Part D,” published in the July 2026 issue of The American Journal of Managed Care ® (AJMC ®), analyzed pr ...
Vitiligo's clinical course splits into segmental and non-segmental presentations, each carrying a distinct prognosis. Dr. Rosmarin explains how disease activity, not just extent, determines whether a ...
This segment explores emerging challenges in treatment sequencing for hormone receptor–positive, HER2-negative metastatic breast cancer as oral selective estrogen receptor degraders move into earlier ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results